Feedback
  • Article / Essay
  • Corrigendum: Nitazoxanide, an antiprotozoal drug, reduces bone loss in…

Corrigendum: Nitazoxanide, an antiprotozoal drug, reduces bone loss in ovariectomized mice by inhibition of RANKL-induced osteoclastogenesis

Affiliation
Department of Rheumatology and Immunology ,Peking University Third Hospital ,Beijing ,China
Li, Chang-hong;
Affiliation
Department of Medicinal Chemistry ,School of Pharmaceutical Sciences ,Peking University Health Science Center ,Beijing ,China
Lü, Zi-rui;
Affiliation
Osteoporosis and Bone Metabolic Diseases Center ,Peking University Third Hospital ,Beijing ,China
Zhao, Zhen-da;
Affiliation
Department of Rheumatology and Immunology ,Peking University Third Hospital ,Beijing ,China
Wang, Xin-yu;
Affiliation
Osteoporosis and Bone Metabolic Diseases Center ,Peking University Third Hospital ,Beijing ,China
Leng, Hui-jie;
Affiliation
Department of Medicinal Chemistry ,School of Pharmaceutical Sciences ,Peking University Health Science Center ,Beijing ,China
Niu, Yan;
Affiliation
Osteoporosis and Bone Metabolic Diseases Center ,Peking University Third Hospital ,Beijing ,China
Wang, Mo-pei

Preview

Category

Published in:
Frontiers in Pharmacology  
Vol. 14 (26.07.2023)
Volume:
14
Date Issued:
26.07.2023
DOI:
10.3389/fphar.2023.1247393
Language:
English
Type of Resource:
Text
Keywords:
nitazoxanide; stat3; osteoclastogenesis; Nfatc1; osteoporosis
DDC subject of DNB:
610 Medical sciences Medicine

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:
open graphic

Rights

License Holder: Copyright © 2023 Li, Lü, Zhao, Wang, Leng, Niu and Wang.

Use and reproduction: